 |
인쇄하기
취소
|
GSK to conduct multinational study for Avodart including Korea
GlaxoSmithKline is set to conduct its multinational clinical study to evaluate the efficacy of the concurrent therapy of dutasteride (brandname: Avodart) plus tamsulosin in patients with benigh prostatic hyperplasia.
The study, which is known as COMBAT (Combination of Avodart and tamsulosin), aims to evaluate the safety and efficacy of dutasteride 0.5 mg, 5-alpha-reductase inhibitor plus tam...
The study, which is known as COMBAT (Combination of Avodart and tamsulosin), aims to evaluate the safety and efficacy of dutasteride 0.5 mg, 5-alpha-reductase inhibitor plus tam...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.